For the obesity treatment group, there was a 6.7% NAION incidence for patients taking semaglutide compared to a 0.8% incidence rate for patients taking other medications for weight loss
The type of drug that will work best for an individual patient depends on several factors, including the severity of their diabetes, their overall health status, their lifestyle, and their personal response to medication
Animashaun A, Kelleher J, Heatley RV, Trejdosiewicz LK, Losowsky MS
The addition of the glucagon component is designed to potentially increase energy expenditure and improve liver fat metabolism
Impact on pharmaceutical companies: While the policy pressures firms to lower prices, it also encourages them to improve efficiency, focus on innovation, and compete on quality rather than marketing
The Proactive Health GLP-1 Program can help you if youre looking to kickstart your health and see improvement in your bloodwork and health tomorrow